Bruker Corporation Financial Statements (BRKR)
|
|
|
|
Report date
|
|
|
30.12.2022 |
31.12.2022 |
01.03.2023 |
31.12.2023 |
29.02.2024 |
|
05.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 531 |
2 531 |
2 531 |
2 965 |
2 965 |
|
3 188 |
|
Operating Income, bln rub |
|
|
432.7 |
432.7 |
456.0 |
442.9 |
436.9 |
|
268.9 |
|
EBITDA, bln rub |
? |
|
519.8 |
545.3 |
517.9 |
557.8 |
599.0 |
|
407.2 |
|
Net profit, bln rub |
? |
|
296.6 |
296.6 |
296.6 |
427.2 |
427.2 |
|
107.0 |
|
|
OCF, bln rub |
? |
|
262.0 |
262.0 |
274.4 |
350.1 |
350.1 |
|
61.3 |
|
CAPEX, bln rub |
? |
|
119.0 |
119.0 |
129.2 |
106.9 |
106.9 |
|
78.6 |
|
FCF, bln rub |
? |
|
143.0 |
143.0 |
145.2 |
243.2 |
243.2 |
|
-17.3 |
|
Dividend payout, bln rub
|
|
|
29.8 |
29.8 |
29.8 |
29.4 |
29.4 |
|
22.6 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
10.0% |
10.0% |
10.0% |
6.88% |
6.88% |
|
21.1% |
|
|
OPEX, bln rub |
|
|
873.0 |
843.3 |
849.7 |
1 054 |
1 076 |
|
1 312 |
|
Cost of production, bln rub |
|
|
1 225 |
1 225 |
1 225 |
1 468 |
1 448 |
|
1 647 |
|
R&D, bln rub |
|
|
235.9 |
235.9 |
235.9 |
294.8 |
294.8 |
|
364.3 |
|
Interest expenses, bln rub |
|
|
18.8 |
16.1 |
16.1 |
36.8 |
16.4 |
|
58.3 |
|
|
Assets, bln rub |
|
|
3 619 |
3 619 |
3 612 |
4 239 |
4 250 |
|
6 113 |
|
Net Assets, bln rub |
? |
|
1 126 |
1 126 |
1 114 |
1 395 |
1 377 |
|
1 825 |
|
Debt, bln rub |
|
|
1 219 |
1 219 |
1 270 |
1 282 |
1 380 |
|
2 297 |
|
Cash, bln rub |
|
|
645.5 |
645.5 |
645.5 |
488.3 |
488.3 |
|
148.1 |
|
Net debt, bln rub |
|
|
573.7 |
573.7 |
624.9 |
793.2 |
891.3 |
|
2 149 |
|
|
Ordinary share price, rub |
|
|
68.4 |
68.4 |
68.4 |
73.5 |
73.5 |
|
56.4 |
|
Number of ordinary shares, mln |
|
|
148.6 |
148.6 |
148.6 |
147.2 |
146.4 |
|
148.1 |
|
|
Market cap, bln rub |
|
|
10 157 |
10 157 |
10 157 |
10 816 |
10 757 |
|
8 351 |
|
EV, bln rub |
? |
|
10 731 |
10 731 |
10 782 |
11 609 |
11 649 |
|
10 501 |
|
Book value, bln rub |
|
|
1 126 |
397 |
385 |
1 395 |
464 |
|
-676 |
|
|
EPS, rub |
? |
|
2.00 |
2.00 |
2.00 |
2.90 |
2.92 |
|
0.72 |
|
FCF/share, rub |
|
|
0.96 |
0.96 |
0.98 |
1.65 |
1.66 |
|
-0.12 |
|
BV/share, rub |
|
|
7.58 |
2.67 |
2.59 |
9.47 |
3.17 |
|
-4.56 |
|
|
EBITDA margin, % |
? |
|
20.5% |
21.5% |
20.5% |
18.8% |
20.2% |
|
12.8% |
|
Net margin, % |
? |
|
11.7% |
11.7% |
11.7% |
14.4% |
14.4% |
|
3.36% |
|
FCF yield, % |
? |
|
1.41% |
1.41% |
1.43% |
2.25% |
2.26% |
|
-0.21% |
|
ROE, % |
? |
|
26.3% |
26.3% |
26.6% |
30.6% |
31.0% |
|
5.86% |
|
ROA, % |
? |
|
8.20% |
8.20% |
8.21% |
10.1% |
10.1% |
|
1.75% |
|
|
P/E |
? |
|
34.2 |
34.2 |
34.2 |
25.3 |
25.2 |
|
78.1 |
|
P/FCF |
|
|
71.0 |
71.0 |
70.0 |
44.5 |
44.2 |
|
-482.7 |
|
P/S |
? |
|
4.01 |
4.01 |
4.01 |
3.65 |
3.63 |
|
2.62 |
|
P/BV |
? |
|
9.02 |
25.6 |
26.4 |
7.76 |
23.2 |
|
-12.4 |
|
EV/EBITDA |
? |
|
20.6 |
19.7 |
20.8 |
20.8 |
19.4 |
|
25.8 |
|
Debt/EBITDA |
|
|
1.10 |
1.05 |
1.21 |
1.42 |
1.49 |
|
5.28 |
|
|
R&D/CAPEX, % |
|
|
198.2% |
198.2% |
182.6% |
275.8% |
275.8% |
|
463.5% |
|
|
CAPEX/Revenue, % |
|
|
4.70% |
4.70% |
5.11% |
3.61% |
3.61% |
|
2.47% |
|
| Bruker Corporation shareholders |
